Amneal Pharmaceuticals (AMRX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 6, 2026, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 5, 2026.

Voting matters and shareholder proposals

• Election of ten directors is on the agenda, with board recommendations provided for each nominee.

• Advisory vote on executive compensation (say-on-pay) is included.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Nominees for director positions include Deb Autor, J. Kevin Buchi, Jeff George, John Kiely, Paul Meister, Ted Nark, Chintu Patel, Chirag Patel, Gautam Patel, and Shlomo Yanai.